Abstract:Background: Prenatal diagnosis of fetal short long bones (SLBs) was reported to be associated with skeletal dysplasias, chromosomal abnormalities, and genetic syndromes. This study aims to identify the genetic causes for fetal short long bones, and retrospectively evaluate the additional diagnostic yield of exome sequencing (ES) for short long bones following the use of conventional genetic testing. Methods: A cohort of ninety-four fetuses with sonographically identified short long bones was analyzed by trio-exome sequencing between January 2016 and June 2021. Fetuses with abnormal results of karyotype or chromosomal microarray analysis were excluded. Variants were interpreted based on ACMG/AMP guidelines. All diagnostic de novo variants were validated by Sanger sequencing. Results: Of the 94 fetuses, 38 (40.4%) were found to carry causal genetic variants (pathogenic or likely pathogenic) in sixteen genes with 38 variants. Five fetuses (5.3%) had variant(s) of uncertain significance. Thirty-five cases (37.2%) were diagnosed as genetic skeletal dysplasias including 14 different diseases that were classified into 10 groups according to the Nosology and Classification of Genetic Skeletal Disorders. The most common disease in the cohort was achondroplasia (28.9%), followed by osteogenesis imperfecta (18.4%), thanatophoric dysplasia (10.5%), chondrogenesis (7.9%), and 3-M syndrome (5.3%). The diagnostic yield in fetuses with isolated short long bones was lower than the fetuses with non-isolated short long bones, but not reached statistical significance (27.3% vs. 44.4%; p = 0.151). Whereas, the rate in the fetuses with other skeletal abnormalities was significantly higher than those with non-skeletal abnormalities (59.4% vs. 32.5%, p = 0.023), and the diagnostic rate was significantly higher in femur length (FL) below -4SDs group compared with FL 2-4SDs below GA group (72.5% vs. 16.7%; p < 0.001). A long-term follow-up showed that outcomes for fetuses with FL 2-4SDs below GA were significantly better than those with FL below -4SDs. Additionally, fourteen (36.8%) novel short long bones-related variants were identified in the present study. Conclusion: The findings suggest that in fetuses with short long bones routine genetic tests failed to determine the underlying causes, exome sequencing could add clinically relevant information that could assist the clinical management of pregnancies. Novel pathogenic variants identified may broaden the mutation spectrum for the disorders and contributes to clinical consultation and subsequent pregnancy examination.

Rapid prenatal diagnosis of skeletal dysplasia using medical trio exome sequencing: Benefit for prenatal counseling and pregnancy management

Prenatal Trio-Based Whole Exome Sequencing in Fetuses with Abnormalities of the Skeletal System

Combined Exome Sequencing and Deep Phenotyping in Highly Selected Fetuses with Skeletal Dysplasia During the First and Second Trimesters Improves Diagnostic Yield

Prenatal Diagnosis by Trio Clinical Exome Sequencing: Single Center Experience

EP07.16: Rapid prenatal diagnosis of fetal short femur using trio clinical exome sequencing

Prenatal diagnosis of skeletal dysplasias using whole exome sequencing in China

Prenatal diagnosis of fetal skeletal anomalies via whole-exome sequencing in a tertiary referral center

Clinical Application of Medical Exome Sequencing for Prenatal Diagnosis of Fetal Structural Anomalies.

Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder

Molecular Diagnosis for 55 Fetuses with Skeletal Dysplasias by Whole‐exome Sequencing: A Retrospective Cohort Study

Whole Exome Sequencing Aids the Diagnosis of Fetal Skeletal Dysplasia

Exome sequencing in fetuses with short long bones detected by ultrasonography: A retrospective cohort study

Application of exome sequencing for prenatal diagnosis of fetal structural anomalies: clinical experience and lessons learned from a cohort of 1618 fetuses

Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities

Non-Invasive Prenatal Diagnosis of Lethal Skeletal Dysplasia by Targeted Capture Sequencing of Maternal Plasma

Development and validation of an expanded targeted sequencing panel for non-invasive prenatal diagnosis of sporadic skeletal dysplasia

Exome sequencing improves genetic diagnosis of fetal increased nuchal translucency

Clinical utility of 24-h rapid trio-exome sequencing for critically ill infants

Trio-whole exome sequencing and preimplantation genetic diagnosis for unexplained recurrent fetal malformations.

Diagnostic Yield of Exome Sequencing in Fetuses with Sonographic Features of Skeletal Dysplasias but Normal Karyotype or Chromosomal Microarray Analysis: A Systematic Review

Simultaneous CNV-seq and WES: an Effective Strategy for Molecular Diagnosis of Unexplained Fetal Structural Anomalies